Mar 12, 2018 Market Comments Off on Neuralstem to Participate at Upcoming Investor Conferences
GERMANTOWN, Md., March 12, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that members of the management team will participate at the following upcoming investor conferences:
Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. The Company has two lead development candidates:
Neuralstem’s diversified portfolio of product candidates is based on its proprietary neural stem cell technology.
Cautionary Statement Regarding Forward Looking Information
This news release contains “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem’s periodic reports, including the Annual Report on Form 10-K for the year ended December 31, 2016, and Form 10-Q for the three and nine months ended September 30, 2017, filed with the Securities and Exchange Commission (SEC), and in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.
Argot Partners (Investor Relations)
Comments Off on Chinese Premier Visits Wuhan as Virus Death Toll Hits 80
Comments Off on Philippine Ilocano basketball tourney tips off in Taichung
Comments Off on WUHAN VIRUS / Taiwan tightens restrictions on people with recent Hubei travel history
Comments Off on U.S. dollar closes higher on Taipei forex market
Comments Off on Think tank raises Taiwan 2020 GDP growth forecast to 2.67%
Comments Off on U.S. brokerage raises target price on TSMC shares to over NT$400